Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Bouguen

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Journal of Crohn'S & Colitis|February 26, 2022
How to Manage Inflammatory Bowel Disease Patients When They Withdraw Anti-Tumour Necrosis Factor [Anti-TNF] Due to Severe Anti-TNF-Induced Skin Lesions? A Multicentre Cohort StudyC Cottron, X Treton, R Altwegg, et al.
The American Journal of Gastroenterology|March 10, 2011
Successive treatment with cyclosporine and infliximab in steroid-refractory ulcerative colitisS Leblanc, M Allez, P Seksik, et al.
Alimentary Pharmacology & Therapeutics|January 10, 2018
Long-term efficacy and safety of ustekinumab in 122 refractory Crohn's disease patients: a multicentre experienceP Wils, Y Bouhnik, P Michetti, et al.
Journal of Crohn'S & Colitis|September 10, 2015
Fistula Plug in Fistulising Ano-Perineal Crohn's Disease: a Randomised Controlled TrialA Senéjoux, L Siproudhis, L Abramowitz, et al.
Clinics and Research in Hepatology and Gastroenterology|April 3, 2019
Online training on how to diagnose anoperineal lesions of Crohn's disease: Do pictures matter? A nationwide randomized studyC Geffrier, V de Parades, L Abramowitz, et al.
Techniques in Coloproctology|September 21, 2017
Anoperineal lesions in Crohn's disease: French recommendations for clinical practiceD Bouchard, L Abramowitz, G Bouguen, et al.
Alimentary Pharmacology & Therapeutics|June 9, 2017
One-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort studyA Amiot, M Serrero, L Peyrin-Biroulet, et al.
Alimentary Pharmacology & Therapeutics|December 19, 2017
Impact of vedolizumab therapy on extra-intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV-IBD cohortS Tadbiri, L Peyrin-Biroulet, M Serrero, et al.
The American Journal of Gastroenterology|August 26, 2015
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-TargetL Peyrin-Biroulet, W Sandborn, B E Sands, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Journal of Crohn'S & Colitis|February 26, 2022
How to Manage Inflammatory Bowel Disease Patients When They Withdraw Anti-Tumour Necrosis Factor [Anti-TNF] Due to Severe Anti-TNF-Induced Skin Lesions? A Multicentre Cohort StudyC Cottron, X Treton, R Altwegg, et al.
The American Journal of Gastroenterology|March 10, 2011
Successive treatment with cyclosporine and infliximab in steroid-refractory ulcerative colitisS Leblanc, M Allez, P Seksik, et al.
Alimentary Pharmacology & Therapeutics|January 10, 2018
Long-term efficacy and safety of ustekinumab in 122 refractory Crohn's disease patients: a multicentre experienceP Wils, Y Bouhnik, P Michetti, et al.
Journal of Crohn'S & Colitis|September 10, 2015
Fistula Plug in Fistulising Ano-Perineal Crohn's Disease: a Randomised Controlled TrialA Senéjoux, L Siproudhis, L Abramowitz, et al.
Clinics and Research in Hepatology and Gastroenterology|April 3, 2019
Online training on how to diagnose anoperineal lesions of Crohn's disease: Do pictures matter? A nationwide randomized studyC Geffrier, V de Parades, L Abramowitz, et al.
Techniques in Coloproctology|September 21, 2017
Anoperineal lesions in Crohn's disease: French recommendations for clinical practiceD Bouchard, L Abramowitz, G Bouguen, et al.
Alimentary Pharmacology & Therapeutics|June 9, 2017
One-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort studyA Amiot, M Serrero, L Peyrin-Biroulet, et al.
Alimentary Pharmacology & Therapeutics|December 19, 2017
Impact of vedolizumab therapy on extra-intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV-IBD cohortS Tadbiri, L Peyrin-Biroulet, M Serrero, et al.
The American Journal of Gastroenterology|August 26, 2015
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-TargetL Peyrin-Biroulet, W Sandborn, B E Sands, et al.
Pageof 3